TEVA didn't start working on their biologics until 2009 so how is follitropin & filgrastim covered under the agreement before TEVA started working on the biologics.
Please correct me if my timing is wrong.
Agreements were revised. Cephalon acquisition also threw in a wrench, which is cause of perceived delay...
Loko seems to think ATRS/TEVA are working on projects in which no agreements have ever been signed. ATRS can't allocate funds to undercover projects unless investors are given some guidance concerning their activities with a partner.